Kamper A-L, Strandgaard S, Leyssac PP
Late outcome of a controlled trial of enalapril treatment in progressive renal failure. Hard end-points and influence of proteinuria.

Nephrol Dial Transplant (Jul) 10:1182-1188 1995

This is a follow-up study of a controlled trial previously demonstrating that enalapril slowed progression of CRF. Since all but 4 pts on ACE inhibitor continued this Rx after study, 70 pts (13 diabetic) were studied at mean 44 mo after trial termination. 12/35 (34%) on enalapril vs. 5/35 (14%) in original control group were alive and not on dialysis (P=0.05, CI 0.5-39.5%). No additive effect of ACE inhibitor and protein restriction was found. (Leehey)

To go back use the BACK button on your browser.
Otherwise click on the desired link to this article below:
CRF by problem area : Progression